Active	Status	Sponsor type	Region	Phase	Filter
5 Active 2 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Roy, Bhaskar
NCT06450886: Long-term Extension Study of Ulviprubart (ABC008) in Subjects with Inclusion Body Myositis	Active, not recruiting	2/3	270	US, RoW	Ulviprubart (ABC008)	Abcuro, Inc.	Inclusion Body Myositis (IBM)	01/29	04/29
NCT05721573: A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis	Active, not recruiting	2/3	231	Europe, Canada, US, RoW	ABC008	Abcuro, Inc., Syneos Health	Inclusion Body Myositis	11/25	12/25
ALKIVIA, NCT05523167 / 2021-001277-23: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy.	Recruiting	2/3	240	Europe, Canada, Japan, US, RoW	EFG PH20 SC, PBO	argenx, argenx BV	Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome	12/26	02/27
NCT06106672: Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis	Recruiting	1/2	54	US	CNP-106, Placebo	COUR Pharmaceutical Development Company, Inc.	Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis, MuSK MG	06/26	08/26
iMMersioN, NCT05988073: A Prospective Longitudinal Study in Adults with Multifocal Motor Neuropathy	Recruiting	N/A	150	Europe, Canada, Japan, US, RoW		argenx	Multifocal Motor Neuropathy	11/25	11/25